These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25154302)

  • 1. NOD-like receptors interfacing the immune and reproductive systems.
    Van Gorp H; Kuchmiy A; Van Hauwermeiren F; Lamkanfi M
    FEBS J; 2014 Oct; 281(20):4568-82. PubMed ID: 25154302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOD-Like Receptors in Infection, Immunity, and Diseases.
    Kim YK; Shin JS; Nahm MH
    Yonsei Med J; 2016 Jan; 57(1):5-14. PubMed ID: 26632377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of Nod-like receptors in microbial recognition and host defense.
    Franchi L; Warner N; Viani K; Nuñez G
    Immunol Rev; 2009 Jan; 227(1):106-28. PubMed ID: 19120480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOD-like receptors: role in innate immunity and inflammatory disease.
    Chen G; Shaw MH; Kim YG; Nuñez G
    Annu Rev Pathol; 2009; 4():365-98. PubMed ID: 18928408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unleashing the therapeutic potential of NOD-like receptors.
    Geddes K; Magalhães JG; Girardin SE
    Nat Rev Drug Discov; 2009 Jun; 8(6):465-79. PubMed ID: 19483708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOD-Like Receptors: Guardians of Intestinal Mucosal Barriers.
    Claes AK; Zhou JY; Philpott DJ
    Physiology (Bethesda); 2015 May; 30(3):241-50. PubMed ID: 25933824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nod-like receptors in intestinal host defense: controlling pathogens, the microbiota, or both?
    Robertson SJ; Girardin SE
    Curr Opin Gastroenterol; 2013 Jan; 29(1):15-22. PubMed ID: 23132210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding and modulating the Toll like Receptors (TLRs) and NOD like Receptors (NLRs) cross talk in type 2 diabetes.
    Prajapati B; Jena PK; Rajput P; Purandhar K; Seshadri S
    Curr Diabetes Rev; 2014 May; 10(3):190-200. PubMed ID: 24828062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NLRs, inflammasomes, and viral infection.
    Jacobs SR; Damania B
    J Leukoc Biol; 2012 Sep; 92(3):469-77. PubMed ID: 22581934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOD-like receptor cooperativity in effector-triggered immunity.
    Griebel T; Maekawa T; Parker JE
    Trends Immunol; 2014 Nov; 35(11):562-70. PubMed ID: 25308923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inflammasome in host defense.
    Chen G; Pedra JH
    Sensors (Basel); 2010; 10(1):97-111. PubMed ID: 22315529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inflammasomes: guardians of the body.
    Martinon F; Mayor A; Tschopp J
    Annu Rev Immunol; 2009; 27():229-65. PubMed ID: 19302040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases.
    Wicherska-Pawłowska K; Wróbel T; Rybka J
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern recognition receptors and control of adaptive immunity.
    Palm NW; Medzhitov R
    Immunol Rev; 2009 Jan; 227(1):221-33. PubMed ID: 19120487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expanding role of NLRs in antiviral immunity.
    Lupfer C; Kanneganti TD
    Immunol Rev; 2013 Sep; 255(1):13-24. PubMed ID: 23947344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate and intrinsic antiviral immunity in skin.
    Kawamura T; Ogawa Y; Aoki R; Shimada S
    J Dermatol Sci; 2014 Sep; 75(3):159-66. PubMed ID: 24928148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs.
    Becker CE; O'Neill LA
    Semin Immunopathol; 2007 Sep; 29(3):239-48. PubMed ID: 17805544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interleukin-1 cytokines, inflammasomes, NOD-signalosomes and autoinflammation].
    Gadola SD
    Z Rheumatol; 2009 Nov; 68(9):712-9. PubMed ID: 19830437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRs in immune privileged sites.
    Rosenzweig HL; Planck SR; Rosenbaum JT
    Curr Opin Pharmacol; 2011 Aug; 11(4):423-8. PubMed ID: 21803656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors and NOD-like receptors: domain architecture and cellular signalling.
    Langefeld T; Mohamed W; Ghai R; Chakraborty T
    Adv Exp Med Biol; 2009; 653():48-57. PubMed ID: 19799111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.